Highlights

[TIGER] QoQ TTM Result on 2018-12-31 [#0]

Stock [TIGER]: TIGER SYNERGY BHD
Announcement Date 28-Feb-2019
Admission Sponsor -
Sponsor -
Financial Year 30-Jun-2019
31-Dec-2018
Profit Trend QoQ -     9.29%    YoY -     36.80%
Quarter Report


View:


Show?  QoQ % Horiz. %

TTM Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 15,552 16,989 16,320 13,971 12,231 10,984 13,313 10.91%
  QoQ % -8.46% 4.10% 16.81% 14.23% 11.35% -17.49% -
  Horiz. % 116.82% 127.61% 122.59% 104.94% 91.87% 82.51% 100.00%
PBT -732 36 -3,431 -3,778 -4,211 -4,127 1,535 -
  QoQ % -2,133.33% 101.05% 9.18% 10.28% -2.04% -368.86% -
  Horiz. % -47.69% 2.35% -223.52% -246.12% -274.33% -268.86% 100.00%
Tax -1 -1 419 419 508 508 178 -
  QoQ % 0.00% -100.24% 0.00% -17.52% 0.00% 185.39% -
  Horiz. % -0.56% -0.56% 235.39% 235.39% 285.39% 285.39% 100.00%
NP -733 35 -3,012 -3,359 -3,703 -3,619 1,713 -
  QoQ % -2,194.29% 101.16% 10.33% 9.29% -2.32% -311.27% -
  Horiz. % -42.79% 2.04% -175.83% -196.09% -216.17% -211.27% 100.00%
NP to SH -733 35 -3,012 -3,359 -3,703 -3,619 1,713 -
  QoQ % -2,194.29% 101.16% 10.33% 9.29% -2.32% -311.27% -
  Horiz. % -42.79% 2.04% -175.83% -196.09% -216.17% -211.27% 100.00%
Tax Rate - % 2.78 % - % - % - % - % -11.60 % -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% -23.97% 0.00% 0.00% 0.00% 0.00% 100.00%
Total Cost 16,285 16,954 19,332 17,330 15,934 14,603 11,600 25.35%
  QoQ % -3.95% -12.30% 11.55% 8.76% 9.11% 25.89% -
  Horiz. % 140.39% 146.16% 166.66% 149.40% 137.36% 125.89% 100.00%
Net Worth 296,139 302,007 297,919 274,832 235,511 229,057 223,428 20.64%
  QoQ % -1.94% 1.37% 8.40% 16.70% 2.82% 2.52% -
  Horiz. % 132.54% 135.17% 133.34% 123.01% 105.41% 102.52% 100.00%
Dividend
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Div 0 0 0 0 0 0 0 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Net Worth 296,139 302,007 297,919 274,832 235,511 229,057 223,428 20.64%
  QoQ % -1.94% 1.37% 8.40% 16.70% 2.82% 2.52% -
  Horiz. % 132.54% 135.17% 133.34% 123.01% 105.41% 102.52% 100.00%
NOSH 1,096,812 888,257 763,896 597,463 490,649 409,032 1,718,678 -25.86%
  QoQ % 23.48% 16.28% 27.86% 21.77% 19.95% -76.20% -
  Horiz. % 63.82% 51.68% 44.45% 34.76% 28.55% 23.80% 100.00%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin -4.71 % 0.21 % -18.46 % -24.04 % -30.28 % -32.95 % 12.87 % -
  QoQ % -2,342.86% 101.14% 23.21% 20.61% 8.10% -356.02% -
  Horiz. % -36.60% 1.63% -143.43% -186.79% -235.28% -256.02% 100.00%
ROE -0.25 % 0.01 % -1.01 % -1.22 % -1.57 % -1.58 % 0.77 % -
  QoQ % -2,600.00% 100.99% 17.21% 22.29% 0.63% -305.19% -
  Horiz. % -32.47% 1.30% -131.17% -158.44% -203.90% -205.19% 100.00%
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 1.42 1.91 2.14 2.34 2.49 2.69 0.77 50.33%
  QoQ % -25.65% -10.75% -8.55% -6.02% -7.43% 249.35% -
  Horiz. % 184.42% 248.05% 277.92% 303.90% 323.38% 349.35% 100.00%
EPS -0.07 0.00 -0.39 -0.56 -0.75 -0.88 0.10 -
  QoQ % 0.00% 0.00% 30.36% 25.33% 14.77% -980.00% -
  Horiz. % -70.00% 0.00% -390.00% -560.00% -750.00% -880.00% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.2700 0.3400 0.3900 0.4600 0.4800 0.5600 0.1300 62.71%
  QoQ % -20.59% -12.82% -15.22% -4.17% -14.29% 330.77% -
  Horiz. % 207.69% 261.54% 300.00% 353.85% 369.23% 430.77% 100.00%
Adjusted Per Share Value based on latest NOSH - 1,468,640
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 1.06 1.16 1.11 0.95 0.83 0.75 0.91 10.70%
  QoQ % -8.62% 4.50% 16.84% 14.46% 10.67% -17.58% -
  Horiz. % 116.48% 127.47% 121.98% 104.40% 91.21% 82.42% 100.00%
EPS -0.05 0.00 -0.21 -0.23 -0.25 -0.25 0.12 -
  QoQ % 0.00% 0.00% 8.70% 8.00% 0.00% -308.33% -
  Horiz. % -41.67% 0.00% -175.00% -191.67% -208.33% -208.33% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.2016 0.2056 0.2029 0.1871 0.1604 0.1560 0.1521 20.64%
  QoQ % -1.95% 1.33% 8.44% 16.65% 2.82% 2.56% -
  Horiz. % 132.54% 135.17% 133.40% 123.01% 105.46% 102.56% 100.00%
Price Multiplier on Financial Quarter End Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 -
Price 0.0500 0.0550 0.0700 0.0900 0.0700 0.1000 0.0300 -
P/RPS 3.53 2.88 3.28 3.85 2.81 3.72 3.87 -5.94%
  QoQ % 22.57% -12.20% -14.81% 37.01% -24.46% -3.88% -
  Horiz. % 91.21% 74.42% 84.75% 99.48% 72.61% 96.12% 100.00%
P/EPS -74.82 1,395.83 -17.75 -16.01 -9.28 -11.30 30.10 -
  QoQ % -105.36% 7,963.83% -10.87% -72.52% 17.88% -137.54% -
  Horiz. % -248.57% 4,637.31% -58.97% -53.19% -30.83% -37.54% 100.00%
EY -1.34 0.07 -5.63 -6.25 -10.78 -8.85 3.32 -
  QoQ % -2,014.29% 101.24% 9.92% 42.02% -21.81% -366.57% -
  Horiz. % -40.36% 2.11% -169.58% -188.25% -324.70% -266.57% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.19 0.16 0.18 0.20 0.15 0.18 0.23 -11.95%
  QoQ % 18.75% -11.11% -10.00% 33.33% -16.67% -21.74% -
  Horiz. % 82.61% 69.57% 78.26% 86.96% 65.22% 78.26% 100.00%
Price Multiplier on Announcement Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 25/11/19 27/08/19 29/05/19 28/02/19 30/11/18 30/08/18 30/05/18 -
Price 0.0750 0.0550 0.0500 0.0800 0.0900 0.0800 0.0250 -
P/RPS 5.29 2.88 2.34 3.42 3.61 2.98 3.23 38.90%
  QoQ % 83.68% 23.08% -31.58% -5.26% 21.14% -7.74% -
  Horiz. % 163.78% 89.16% 72.45% 105.88% 111.76% 92.26% 100.00%
P/EPS -112.22 1,395.83 -12.68 -14.23 -11.93 -9.04 25.08 -
  QoQ % -108.04% 11,108.12% 10.89% -19.28% -31.97% -136.04% -
  Horiz. % -447.45% 5,565.51% -50.56% -56.74% -47.57% -36.04% 100.00%
EY -0.89 0.07 -7.89 -7.03 -8.39 -11.06 3.99 -
  QoQ % -1,371.43% 100.89% -12.23% 16.21% 24.14% -377.19% -
  Horiz. % -22.31% 1.75% -197.74% -176.19% -210.28% -277.19% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.28 0.16 0.13 0.17 0.19 0.14 0.19 29.47%
  QoQ % 75.00% 23.08% -23.53% -10.53% 35.71% -26.32% -
  Horiz. % 147.37% 84.21% 68.42% 89.47% 100.00% 73.68% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program
 
 

605  230  568 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FOCUS 0.06-0.005 
 GOCEAN 0.0450.00 
 MTOUCHE 0.285+0.005 
 TANCO-WB 0.07+0.02 
 PERMAJU 0.1450.00 
 TANCO 0.145+0.01 
 MINDA 0.145+0.02 
 UCREST 0.30+0.005 
 TAWIN-OR 0.065-0.005 
 CAREPLS 2.41+0.05 

FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Chinese Sinopharm broke Western Pharmaceutical Industry’s monopoly - Koon Yew Yin Koon Yew Yin's Blog
2. World’s largest pig farm in China will 'produce' 2 million pigs per year - Koon Yew Yin Koon Yew Yin's Blog
3. OCK - The Unfaltering Tower OCK - The 5G Battle by Zyke42
4. China’s Sinovac shot found highly effective in real world study Good Articles to Share
5. TWO POWERFUL FACTORS WHY PALM OIL BULL RUN CAN LAST MUCH LONGER THIS ROUND, Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
6. FCPO FOR MAY 2021 NOW IS RM4,880 (TIME WHEN ALL GOES DOWN PALM OIL UP: SO BUY PALM OIL SHARES ON SALE, Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
7. The Competitive Edge of NEXGRAM (0096) in Vaccine Passport and Digital Facilitation Services: THE NEW GEM IN HEALTHCARE Nexgram (0096) - THE NEW GEM IN HEALTHCARE
8. When will the pandemic end? Out of the box
PARTNERS & BROKERS